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Abstract Murine monoclonal subunit-specific antibodies 
against heterooctameric phosphofructokinase-1 from Saccharo- 
myces cerevisiae exhibiting no cross-reactivity were purified and 
characterized regarding complex formation with the native en- 
zyme, immunological reactivity to the SDS-denatured subunits 
originating from native and proteolytically truncated 
phosphofructokinase, and protection against proteolytic degrada- 
tion. Strong complex formation was found with one cu-specific 
antibody. Western blotting employing different enzyme forms 
allowed to localize epitope sites of the cY-polypeptide chain. Mon- 
oclonal antibodies protect phosphofructokinase-1 against chy- 
motryptic degradation. 
Key words; Phosphofructokinase (yeast); Monoclonal 
antibody; Subunit-specificity; Proteolysis 
1. Introduction 
The octameric phosphofructokinase-1 from Succharomyces 
cerevisiae (Pfk-1) is composed of two types of subunits (CZ and 
p) in equal ratio which are encoded by the genes PFKI and 
PFK2, respectively [1,2]. Their deduced amino acid sequences 
show about 20% of homology in the N- and C-terminal regions 
and more than 50% of homology in the middle part of both 
polypeptide chains [3]. 
Therefore, polyclonal antibodies raised against the native 
enzyme should recognize both types of subunits. In fact, in 
earlier studies applying two-dimensional immunoelectro- 
phoresis we could demonstrate that polyclonal antibodies are 
capable of distinguishing between c1 and p as indicated by 
crossing precipitation lines [4]. This finding was the first evi- 
dence for the existence of different types of subunits in yeast 
Pfk-1. In addition, the fractionation of polyclonal antibodies 
against Pfk-1 by affinity chromatography on the immobilized 
separated subunits resulted in three fractions: antibodies which 
recognize both types of subunits, antibodies which are exclu- 
sively directed against the a-polypeptide chain, and antibodies 
which specifically bind to the p-subunit [5]. 
*Corresponding author. Fax: (49) (341) 7164483. 
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Abbreviations: Ptk-1, phosphofructokinase-1 (EC 2.7.1.11); mAb, mon- 
oclonal antibody; HAT, hypoxanthin-aminopterin-thymidin; DMEM, 
Dulbecco’s modified Eagle medium; PMSF, phenylmethylsulfonyl flu- 
oride; SDS, sodium dodecyl sulphate; aa, amino acid of unknown 
structure. 
All these antibodies were found to inhibit the catalytic activ- 
ity of the enzyme, however, to different extents. 
In this paper, the production of murine monoclonal antibod- 
ies distinctively recognizing each type of subunits of Pfk-1 with- 
out showing any cross-reactivity is described. The antibodies 
were characterized regarding complex formation with the na- 
tive enzyme, immunological reactivity to the denatured sub- 
units originating from native and proteolytically truncated 
yeast Pfk-1, and protecting effect against proteolytic degrada- 
tion. 
2. Experimental 
2.1. Reagents and enzymes 
The enzyme was purified according to Hofmann and Kopperschlager 
[6], with minor modifications. Ammonium sulphate of the first fraction- 
ated precipitation of the enzyme was replaced by poly(ethylene glycol) 
6000 (4% and 12%, respectively). As source the recombinant strain PSl 
of Saccharomyces cerevisiae (MATa ura3-52 IeuZ-3,112 his4-519pep4-3 
gal2 cir’) carrying the PFKl and PFK2 gene in a multicopy vector was 
used. PSI is the cir’-form of the strain PS2 described by Seeboth et al. 
[71. 
The biochemicals for the Ptk-1 assay were from Boehringer 
(Mannheim, Germany). All other analytical reagent grade chemicals 
used were from Merck (Darmstadt, Germany) or Serva (Heidelberg, 
Germany). 
2.2. Methods 
2.2.1. Production of monoclonal antibodies. Female BALB/c mice 
(10 weeks old) were immunized by intraperitoneal injection of 100 pg 
purified Pfk-1 in complete Freund’s adjuvant. 12 weeks after the first 
injection, the animals were boosted on three consecutive days with 50 
pg phosphofructokinase dissolved in 50 mM sodium phosphate buffer, 
pH 7.0, 150 mM sodium chloride. One day after the last injection, 
spleen cells (3 x 10’) were fused with mouse myeloma cells (P3-X63- 
Ag8.653) using polyethylene glycol 1500 according to Kiihler and Mil- 
stein [8]. 
Hybridoma were grown in DMEM (Gibco, Berlin, Germany) supple- 
mented with HAT in the presence of 10% fetal calf serum. Positive 
clones were recognized by screening the supernatants in an ELISA 
using native Ptk-1 for coating 96-well microtiter plates (Nunc, 
Wiesbaden, Germany). The class and subclass specificity was deter- 
mined by using a commercial kit (Virotec, Riisselsheim, Germany). The 
selected clones were recloned by the limiting dilution method. Subunit- 
specificity was assessed from the recognition of the a- and b-chain 
electroblotted from SDS-polyacrylamide gels (Western blot- 
ting). 
2.2.2. Pur$cation of monoclonal antibodies. Subunit-specific 
clones were grown in DMEM containing 10% fetal calf serum at 37°C 
for several days in culture flasks. The culture supernatant was collected 
and the protein was precipitated with ammonium sulphate (100% satu- 
ration) at 4°C followed by dialysis against 20 mM sodium phosphate 
buffer, pH 7.0. The dialyzed protein was applied onto a protein A- 
sepharose column equilibrated with the dialysis buffer. The protein was 
eluted with 100 mM citrate buffer, pH 3.0. For immediate neutraliza- 
tion, 1 M Tris-HCI, pH 7.0, was used. The antibodies were concentrated 
again by ammonium sulphate precipitation, re-dissolved in 50 mM 
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Fig. 1. Truncated polypeptide chains of phosphofructokinase from S. cerevisiue (according to [9]). 
sodium phosphate buffer, pH 7.0, containing 150 mM NaCl, precipi- 
tated at ammonium sulphate saturation and stored at 0°C. 
2.2.3. Polyacrylamide gel electrophoresis and Western blotting. 
SDS-polyacrylamide gel electrophoresis was performed in a Bio-Rad 
Mini-Protean II Dual slab cell apparatus as described elsewhere [9] 
using 7.5% acrylamide running gels. The subunit specificity of the 
monoclonal antibodies was checked by immunoblotting according to 
Towbin et al. [lo]. SDS-denatured purified Pfk-1 (5-1Opg per lane) was 
subjected to SDS-polyacrylamide gel electrophoresis, followed by elec- 
trotransfer of the separated subunits to a nitrocellulose membrane NC 
45 (Serva, Heidelberg, Germany). The membrane was washed, tempo- 
rarily stained with Ponceau S (0.2 g dye per 100 ml of 12% trichlo- 
roacetic acid), and then treated with the respective monoclonal anti- 
body as described by Clifton and Fraenkel [l 11. Detection was carried 
out with sheep anti-mouse immunogobulin/peroxidase conjugate 
(Boehringer, Mannheim. Germany). 
2.2.4. Assay oj’phosphofructokinase activity. The catalytic activity 
of Pfk-1 was measured spectrophotometrically at 25°C using a coupled 
enzyme assay containing 100 mM imidazole- HCl, pH 7.2, 3 mM Fru 
6-P, 0.6 mM ATP, 1 mM AMP, 5 mM MgSO,, 5 mM (NH&SO,, 0.2 
mM NADH, aldolase (1 U/ml), glycerolphosphate dehydrogenase (1.5 
U/ml), and triosephosphate isomerase (5 U/ml). The reaction was 
started by the addition of 20-50 ~1 Pfk-1 appropriately diluted with 50 
mM sodium phosphate buffer, pH 7.0. 
2.2.5. HPLC size-exclusion chromatography. Isocratic size-exclu- 
sion chromatography was performed by FPLC on a Superose 12 HR 
lo/30 column (Pharmacia, Uppsala, Sweden) or on a Biosil SEC-400 
column (Bio-Rad) coupled to a Pharmacia HPLC-chromatograph. The 
column was equilibrated and run with 50 mM sodium phosphate buffer 
containing 150 mM NaCl, pH 7.0, at a flow-rate of 1 ml/min. In some 
experiments sodium chloride was omitted. The absorbance of the efllu- 
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Fig. 2. Detection of immunocomplexes consisting of u-subunit-specific monoclonal antibody and octameric phosphofructokinase from S. cerevisiae. 
A mixture consisting of the mAb a-F3 and native Plk-1 was fractionated on a Superose 12 HR lo/30 HPLC column in 50 mM sodium phosphate 
buffer, pH 7.0, 150 mM NaCl. The protein amounts (antibody/phosphofructokinase) applied onto the column in 100 ~1 buffer were (a) 50/O pg; (b) 
50/10 pg; (c) 50/50 pug; (d) 50/100 pg; and (e) O/100 pg, respectively. The relative retention time (quotient of the elution time of the corresponding 
protein and the elution time of dinitrophenyl alanine x 100) of 37,48, and 60 corresponds to a molecular mass of higher than 1,300 kDa, 708 kDa, 
and 141 kDa, respectively, as estimated from a calibration curve. 
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ent was continuously monitored at either 226 nm or 280 nm. Both 
columns were calibrated with Sigma standard proteins. 
2.2.6. Exposure of PJk-I to chymotrypsin. Pfk-1 dissolved in 50 
mM sodium phosphate buffer, pH 7.0, was mixed with the respective 
mAb dissolved in the same buffer to give final concentrations of 5 pM, 
respectively, related to the half molecule of Pfk-1 (2 mg Pfk-l/ml; 0.75 
mg mAb/ml) and was incubated for 15 min at 23S25”C. Chymotrypsin 
was added (final concentration 250,@ml) and samples were withdrawn 
periodically for assaying Pfi-1 activity. Proteolysis was stopped after 
4 h by the addition of PMSF (final concentration 1 mM). 
3. Results 
3.1. Characterization of mAbs by Western blotting with different 
forms of phosphofructokinase 
From hybridoma cells of mice previously immunized with 
native Pfk-1 four a-specific and five B-specific mAbs were se- 
lected and characterized as indicated in Table 1. With the ex- 
ception of mAb p-4B3 which was found to be IgG2a all other 
mAbs belong to the IgGl subclass. 
In order to localize the interacting epitopes of P&-l, the 
proteolytically modified forms of the enzyme depicted in Fig. 
1 were employed in Western blot analysis. As seen in Table 1, 
the complete set of /?-specific mAbs reacted with all the frag- 
ments of the B-chain. Similarly, mAb a.-3ElO gave a signal with 
the native as well as with all forms of the truncated a-subunit. 
The mAb a-3G7 recognized native 21 S-Pa-l, 17 S-Pfk-1 and 
13 S-Pfk-1. In contrast, mAb a-F3 was reactive with native 21 
S- and 13 S-Pfk-1 only, whereas mAb a-3B3 recognized the 21 
S- and the 17 S-enzyme. 
3.2. Size exclusion chromatography of mAb-Pjk-I complexes 
For studying the interaction of subunit-specific antibodies 
with the oligomeric, non-denatured Pa-1 (21 S), antigen and 
mAb were incubated at different molar ratios. The mixtures 
were fractionated on a Superose 12HR lo/30 FPLC column or, 
alternatively, on a Biosil SEC 400 column. 
A stable immunocomplex consisting of the subunit-specific 
antibody and octameric Pfk-1 was identified with mAb a-F3 
only (Fig. 2). Due to the molecular weight to be expected of 
approximately 1,000 kDa the complex appeared in the void 
volume of the column. Complex formation turned out to occur 
within seconds as seen from gel filtration experiments where 
both proteins were mixed immediately before application onto 
the column. A prolongation of the incubation time up to 3 h 
did not influence the extent of complex formation. 
Table 1 
Reactivity of subunit-specific monoclonal antibodies to truncated 
forms of yeast phosphofructokinase-1 as detected by Western-blot 
analysis 
Monoclonal 21 s- 17 s- 13 s- 12 s- 
antibody Pfk-1 Pfk-1 Pfk-1 Pfk-1 
a-F3 + _ + _ 
a-3G7 + + + _ 
a-3B3 + + - _ 
a-3ElO + + + + 
$1::: 
+ + + + 
+ + + + 
/X-lBl1 + + + + 
/I-4B3 + + + + 
p-3B5 + + + + 
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Fig. 3. Time course of the catalytic activity of phosphofructokinase 
from S. cerevisiae during proteolysis in the presence of monoclonal 
antibodies. Pfk-1 (2 mg/ml) dissolved in 50 mM sodium phosphate 
buffer, pH 7.0, was incubated at 23-25°C for 15 min with equimolar 
amounts of mAbs before chymotrypsin was added in a volume of 20 
~1 (final concentration 250 pg/ml). 20 ,~l samples were withdrawn peri- 
odically and assayed for Pflc-1 activity. (A) 0, control without antibody; 
??, mAb a-3B3; o, mAb a-ElO; n, mAb a-3G7; ??, mAb a-F3. (B) o, 
control without antibody; o, mAb j?-1Bll; ??, mAb ,&3D4; ??, mAb 
/S2G3; n, mAb B-3B5; ??, mAb ,&4B3. 
Immunocomplexes of Pfk-1 with B-3D4 and j?-lBl1 were 
also detected using the antibody in excess. 
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Fig. 4. SDS-polyacrylamide gel electrophoresis of phosphofructokinase from S. cerevisiae after chymotryptic digestion. The mixtures of Ptk-1, mAb 
and chymotrypsin, characterized in Fig. 3, were incubated for 4 h at 23-25°C. Proteolytic activity was stopped by the addition of PMSF (final 
concentration 1 mM). The samples were heat-denatured in 3 vols. SDS-cocktail (0.06 M Tris-HCl, pH 6.8, 10% glycerol, 2% SDS, 0.5 M 
2-mercaptoethanol, 0.0001% Bromophenol blue). 10 pg protein/lane were subjected to electrophoresis (45 min at 200 V). 
3.3. Protective effect of mAbs against proteolytic degradation of 
Pjk-1 
The influence of the mAbs on the chymotryptic degradation 
of Pfk-1 was studied by analyzing both catalytic activity and 
peptide pattern following proteolytic digestion. A possible inhi- 
bition of chymotryptic activity by mouse immunoglobulin was 
ruled out by a control experiment. 
As depicted in Fig. 3A, the activity of Pfk-1 decreased rapidly 
within 4 h reaching 10% in the absence of any mAb due to the 
chymotryptic action. After addition of the mAb a-3B3, a-3E10, 
a-3G7 or a-F3, respectively, the enzyme activity was more or 
less preserved. Maximum protection with remaining activity of 
80-90% was found in the presence of mAb a-3B3 and a-3ElO 
whereas a-3G7 and a-F3 were found to act less protective. 
Among the P-specific antibodies, p-1Bll and /I-3D4 almost 
completely protected the enzyme against proteolytic inactiva- 
tion (Fig. 3B). The presence of mAbs /3-3B5, /I-3G2, or P-4B3 
did not influence chymotryptic inactivation of Pfk- 1. 
In order to compare the changes in enzyme activity with 
alterations in the structure of Pfk-1, the subunit pattern was 
analyzed following chymotrypsin treatment by SDS-poly- 
acrylamide gel electrophoresis (Fig. 4). 
No significant proteolytic degradation of the a- or p-subunit 
of Pfk-1 was observed in the presence of the mAbs a-3El0, 
a-3G7, ,8-l B 11, or /?-3D4, respectively. In contrast, the control 
experiment lacking the mAb revealed a complete degradation 
of the two types of subunits to low molecular weight fragments. 
The effect of mAbs a-3B3 and a-F3 is of particular interest: 
a limited degradation of both subunits was observed, leading 
to a pair of peptides with molecular weights of 87 and 76 kDa, 
respectively. In the presence of mAb a-3B3, the a-polypeptide 
chain seems to be more protected than in presence of a-F3. 
Western blotting of the peptides with monoclonal antibodies 
revealed the 87 kDa-band originates from the a- and the 76 
kDa-peptide from the P-subunit, respectively. 
4. Discussion 
Despite significant similarities in the primary structure of the 
a- and B-chain of yeast Pfk-1, monoclonal antibodies were 
generated and purified exhibiting subunit specificity. The inter- 
action of a- and P-specific mAbs with SDS-denatured Pfk- 1 as 
studied by Western blotting resulted in responses depending on 
the type of the truncated subunit applied and suggesting the 
following classification: class I, mAbs which bind either to the 
N- or C-terminal part of the polypeptide chains, and class II, 
mAbs recognizing epitopes that belong to the inner part of the 
subunits. 
Those mAbs which recognize peripheral epitopes (a-F3, a- 
3G7 and a-3B3) are exclusively a-specific. The mAb a-F3 is 
able to detect 21 S- and 13 S-Pfk-1 but not the 17 S- and 12 
S-form. In the first two enzyme species, the complete N-termi- 
nal part of the a-polypeptide chain is preserved, whereas the 
latter two are lacking it (Fig. 1). This finding suggests a localiz- 
ation of the epitope for mAb a-F3 within the N-terminal 200 
amino acids of the a-polypeptide chain. 
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The mAb a-3B3 recognized both native Pfk-1 and the 17 
S-enzyme but did not interact with the 13 S- and 12 S-form. 
Because the a-chain is degraded in the latter two enzyme species 
at the C-terminus, it becomes likely that the epitope for a-3B3 
belongs to the C-terminal part of the subunit. 
Similarly, a C-terminal epitope was recognized by the mAb 
a-3G7. This antibody showed interaction with all forms of 
Ptk-1 with the exception of the 12 S-species. Since the cleavage 
site of the a-chain to form 12 S-Pfk-1 was found in the vicinity 
of aas3” as calculated from the released peptide [9], and the 
cleavage site in the a-polypeptide chain to form 13 S-Pfk-1 is 
Va1914 (see Fig. 1) the conclusion can be drawn that the epitope 
for the mAb a-3G7 is localized between aax3’ and Lys913 of the 
c+polypeptide chain. The class I antibodies may be taken as 
indication for the unique exposure of the a-ends of the polypep- 
tide chain. 
In contrast, the B-specific mAbs investigated were reactive to 
all forms of truncated Pfk-1. This finding indicates that their 
epitopes are localized in the middle part of the P-polypeptide 
chain which is unaffected in the course of limited proteolysis. 
Pfk-1 is rapidly degraded by the attack of chymotrypsin and 
other proteases which is followed by inactivation and by the 
release of peptides. Substrates and effecters of the enzyme 
turned out to be capable of maintaining enzyme activity due to 
a limitation of proteolysis [9]. 
In this study, four a-specific mAbs (a-3B3, a-3E10, a-3G7 
and a-F3) were found to preserve enzyme activity from chy- 
motryptic inactivation. Therefore, these antibodies must com- 
plex the enzyme under the conditions of proteolysis. However, 
in most cases (with the exception of a-F3) low complex stability 
allows dissociation of the immunocomplex during HPLC gel 
filtration. 
From the set of B-specific mAbs only p- 1 Bl 1 and P-3D4 are 
capable to protect the enzyme from proteolytic inactivation 
although complex formation could be detected by HPLC gel 
filtration with /?-3D4 only. 
The degree of chymotryptic digestion was found to coincide 
qualitatively with the extent of inactivation. Independent of the 
type of antibody essentially no subunit degradation was de- 
tected with the majority of antibodies completely preserving 
enzyme activity with the exception of a-3B3 and a-F3. In the 
presence of a-3B3, the degradation of the a-subunit was sub- 
stantially retarded finally leading to a truncated polypeptide of 
87 kDa. It should be stressed, that the accompanying limited 
breakdown of the P-subunit to a 76 kDa fragment was unex- 
pected. Obviously, under these conditions an enzyme species is 
formed which is similar or identical to the truncated but catalyt- 
ically active 17 S-Pfk-1 [9]. In a resembling way, the chymotryp- 
tic proteolysis of Pfk-1 occurring in the presence of a-F3 gener- 
ates a pair of truncated polypeptides with comparable molecu- 
lar weights. However, the protection of the native a-subunit is 
less pronounced than in the case of a-3B3. 
The results of this study let us assume that the Pfk-1 antibody 
interaction is based on sequence rather than on conformational 
determinants of the enzyme. The P-type antibodies react with 
all forms of Pfk-1 independent of the oligomeric state of the 
enzyme. Also, a-type antibodies recognize both the octameric 
and the tetrameric enzyme except for mAb a-3B3 which is 
reactive with the octameric form of Pfk-1 only. This behaviour 
could also be explained as a structure-specific interaction with 
epitopes being present exclusively in octameric Pfk- 1. 
Acknowledgements: We are indebted to Dr. Jtirgen Heinisch, Institute 
of Microbiology, University of Dusseldorf, Germany, for providing the 
yeast strain. The skilful technical assistance of Mrs G. Lorenz and Mrs 
E. Mtiller (Leipzig) is gratefully acknowledged. 
References 
[l] Kopperschllger, G., Bar, J., Nissler, K. and Hofmann, E. (1977) 
Eur. J. Biochem. 81, 317-325. 
[2] Heinisch, J., Ritzel, R.G., von Borstel, R.C., Aguilera, A., Rodi- 
cio. R. and Zimmermann. F.K. (1989) Gene 78. 3099321. 
[3] Arvanitidis, A. and Heinisch, J. (1994) J. Biol. Chem. 269, 891 l- 
8918. 
[4] Herrmann, K., Diezel, W., Kopperschlager, G. and Hofmann, E. 
(1973) FEBS Lett. 36, 190-192. 
[5] Kriegel, T., Huse, K. and Kopperschlager, G. (1988) Biomed. 
Biochim. Acta 47, 705-7 11. 
[6] Hofmann, E. and Kopperschllger, G. (1982) Methods Enzymol. 
90, 49960. 
[7] Seeboth, P.G., Bohnsack, K. and Hollenberg, C.P. (1990) 
J. Bacterial. 172, 6788685. 
[8] Kiihler, G. and Milstein, C. (1975) Nature 256, 495497. 
[9] Kopperschlager, G., Bar, J. and Stellwagen, E. (1993) Eur. J. 
Biochem. 217, 527-533. 
[lo] Towbin, H., Staehlin, T. and Gordon, J. (1979) Proc. Natl. Acad. 
Sci. USA 76, 43504354. 
[l l] Clifton, D. and Fraenkel, D.G. (1982) Biochemistry 21, 1935- 
1942. 
